A molecular cytogenetic analysis of 7q31 in prostate cancer.

[1]  Haojie Huang,et al.  Fish mapping of YAC clones at human chromosomal band 7q31.2: Identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer , 1998, Genes, chromosomes & cancer.

[2]  S. Scherer,et al.  Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas , 1997, Nature Genetics.

[3]  F. Toledo,et al.  Expression of Fragile Sites Triggers Intrachromosomal Mammalian Gene Amplification and Sets Boundaries to Early Amplicons , 1997, Cell.

[4]  D. Bostwick,et al.  Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.

[5]  S. Scherer,et al.  Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET. , 1996, Oncogene.

[6]  D. Bostwick,et al.  Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. , 1996, The American journal of pathology.

[7]  P. Meltzer,et al.  Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. , 1996, Cancer research.

[8]  P. Carroll,et al.  Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. , 1996, Cancer research.

[9]  P. Oefner,et al.  Accurate and absolute quantitative measurement of gene expression by single-tube RT-PCR and HPLC. , 1995, Genome research.

[10]  D. Bostwick,et al.  Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. , 1995, Cancer research.

[11]  P. Humphrey,et al.  Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. , 1995, The American journal of pathology.

[12]  T. H. van der Kwast,et al.  Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: Analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias , 1995, Genes, chromosomes & cancer.

[13]  J. Zenklusen,et al.  Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. , 1995, Cancer research.

[14]  B. Ponder,et al.  A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. , 1995, Oncogene.

[15]  T. Visakorpi,et al.  Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. , 1995, Cancer research.

[16]  P. Troncoso,et al.  Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. , 1994, Cancer research.

[17]  I. Bièche,et al.  (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Bergstralh,et al.  Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. , 1994, Cancer research.

[19]  J Piper,et al.  Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Hofstra,et al.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma , 1994, Nature.

[21]  K. Chew,et al.  Loss of heterozygosity and p53 gene mutations in breast cancer. , 1994, Cancer research.

[22]  P. Troncoso,et al.  Trisomy 7: A potential cytogenetic marker of human prostate cancer progression , 1994, Genes, chromosomes & cancer.

[23]  I. Bièche,et al.  Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer , 1992, The Lancet.

[24]  F. Mitelman,et al.  Cytogenetic analysis of 57 primary prostatic adenocarcinomas , 1992, Genes, chromosomes & cancer.

[25]  P. Comoglio,et al.  c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. , 1991, Oncogene.

[26]  A. Balmain,et al.  Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7 , 1990, Cell.

[27]  J. V. van Dongen,et al.  Location of genes involved in invasion and metastasis on human chromosome 7. , 1987, Cancer research.

[28]  J. Yunis,et al.  Constitutive fragile sites and cancer. , 1984, Science.

[29]  A. de la Chapelle,et al.  Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites. , 1984, Cytogenetics and cell genetics.